Paper3933818
A phase I trial of recombinant gamma interferon in patients with cancer.
Foon KA and 7 others. Cancer Immunol Immunother, 1985. Cited by 103 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. A phase I trial of recombinant gamma interferon in patients with cancer. Papers, record 3933818. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3933818
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interferon-gamma | Major topic |
| Neoplasms | Major topic |
| Recombinant Proteins | Major topic |
| Drug Evaluation | |
| Humans | |
| Immunotherapy |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| N01-CO-23910 | NCI NIH HHS | United States | N01CO023910 | PubMed and NIH |
Source NIH RePORTER
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6,159,812 | Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma. | Ann Intern Med | 1980 | https://conductscience.org/library/papers/6159812 | PubMed |
| 2 | 6,403,609 | Recombinant interferon-gamma increases HLA-DR synthesis and expression. | J Immunol | 1983 | https://conductscience.org/library/papers/6403609 | PubMed |
| 3 | 6,752,447 | A multiple-dose phase I trial of recombinant leukocyte A interferon in cancer patients. | JAMA | 1982 | https://conductscience.org/library/papers/6752447 | PubMed |
| 4 | 6,427,223 | Natural human interferon-gamma. Complete amino acid sequence and determination of sites of glycosylation. | J Biol Chem | 1984 | https://conductscience.org/library/papers/6427223 | PubMed |
| 5 | 6,332,565 | Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomas. | Ann Intern Med | 1984 | https://conductscience.org/library/papers/6332565 | PubMed |
| 6 | 6,192,145 | Recombinant immune interferon increases immunoglobulin G Fc receptors on cultured human mononuclear phagocytes. | J Clin Invest | 1983 | https://conductscience.org/library/papers/6192145 | PubMed |
| 7 | 91,516 | Enhanced expression of HLA antigens and beta 2-microglobulin on interferon-treated human lymphoid cells. | Eur J Immunol | 1979 | https://conductscience.org/library/papers/91516 | PubMed |
| 8 | 6,319,748 | Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons. | J Virol | 1984 | https://conductscience.org/library/papers/6319748 | PubMed |
| 9 | 6,168,319 | Follow-up observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma. | Blood | 1981 | https://conductscience.org/library/papers/6168319 | PubMed |
| 10 | 6,178,592 | Comparison of effects of leukocyte and fibroblast interferon on immunological parameters in cancer patients. | Eur J Cancer Clin Oncol | 1982 | https://conductscience.org/library/papers/6178592 | PubMed |
| 11 | 362,211 | Preliminary observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma. | N Engl J Med | 1978 | https://conductscience.org/library/papers/362211 | PubMed |
| 12 | 6,689,734 | Alpha interferon for induction of remission in hairy-cell leukemia. | N Engl J Med | 1984 | https://conductscience.org/library/papers/6689734 | PubMed |
| 13 | 6,342,490 | Recombinant leukocyte A interferon in advanced breast cancer. Results of a phase II efficacy trial. | Ann Intern Med | 1983 | https://conductscience.org/library/papers/6342490 | PubMed |
| 14 | 6,336,662 | Renal cell carcinoma: antitumor effects of leukocyte interferon. | Cancer Res | 1983 | https://conductscience.org/library/papers/6336662 | PubMed |
| 15 | 6,470,751 | Phase II study of low-dose recombinant leukocyte A interferon in disseminated malignant melanoma. | J Clin Oncol | 1984 | https://conductscience.org/library/papers/6470751 | PubMed |
| 16 | 6,091,541 | Potentiating effect of murine interferon-gamma-containing lymphokine preparations on the antiviral and antiproliferative effects of murine interferon-alpha/beta: identification of the potentiation factor as murine interferon-gamma itself. | Antiviral Res | 1984 | https://conductscience.org/library/papers/6091541 | PubMed |
| 17 | 6,835,320 | Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma. | N Engl J Med | 1983 | https://conductscience.org/library/papers/6835320 | PubMed |
| 18 | 468,410 | Increased monocyte-mediated cytostasis of lymphoid cell lines in breast and lung cancer patients. | Int J Cancer | 1979 | https://conductscience.org/library/papers/468410 | PubMed |
| 19 | 84,901 | Interferon therapy in myelomatosis. | Lancet | 1979 | https://conductscience.org/library/papers/84901 | PubMed |
| 20 | 6,430,557 | Pharmacokinetic study of partially pure gamma-interferon in cancer patients. | Cancer Res | 1984 | https://conductscience.org/library/papers/6430557 | PubMed |
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 103 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,480,219 | Long-acting pegylated interferon gamma sensitizes AML cells to killing by donor T cells. | Blood Adv | 2026 | https://conductscience.org/library/papers/42480219 | PubMed |
| 39,885,917 | Successful treatment of a chronic myeloid leukemia patient with extreme thrombocytosis by a combination of imatinib and interferon‑α: A case report. | Exp Ther Med | 2025 | https://conductscience.org/library/papers/39885917 | PubMed |
| 38,487,528 | A phase I trial of SON-1010, a tumor-targeted, interleukin-12-linked, albumin-binding cytokine, shows favorable pharmacokinetics, pharmacodynamics, and safety in healthy volunteers. | Front Immunol | 2024 | https://conductscience.org/library/papers/38487528 | PubMed |
| 36,481,777 | Long-term durability of immune responses to the BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex. | Sci Rep | 2022 | https://conductscience.org/library/papers/36481777 | PubMed |
| 36,003,373 | Substratum interactions determine immune response to allogeneic transplants of endothelial cells. | Front Immunol | 2022 | https://conductscience.org/library/papers/36003373 | PubMed |
| 35,747,815 | Targeting MDK Abrogates IFN-γ-Elicited Metastasis inCancers of Various Origins. | Front Oncol | 2022 | https://conductscience.org/library/papers/35747815 | PubMed |
| 34,909,751 | Solar UVR and Variations in Systemic Immune and Inflammation Markers. | JID Innov | 2021 | https://conductscience.org/library/papers/34909751 | PubMed |
| 34,068,946 | Data-Driven Mathematical Model of Osteosarcoma. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34068946 | PubMed |
| 33,291,412 | Data Driven Mathematical Model of Colon Cancer Progression. | J Clin Med | 2020 | https://conductscience.org/library/papers/33291412 | PubMed |
| 33,110,704 | Transient Transfection of the Respiratory Epithelium with Gamma Interferon for Host-Directed Therapy in Pulmonary Tuberculosis. | Mol Ther Nucleic Acids | 2020 | https://conductscience.org/library/papers/33110704 | PubMed |
| 31,827,180 | Cell-based interferon gene therapy using proliferation-controllable, interferon-releasing mesenchymal stem cells. | Sci Rep | 2019 | https://conductscience.org/library/papers/31827180 | PubMed |
| 31,324,057 | Cryopreserved Human Natural Killer Cells Exhibit Potent Antitumor Efficacy against Orthotopic Pancreatic Cancer through Efficient Tumor-Homing and Cytolytic Ability (Running Title: Cryopreserved NK Cells Exhibit Antitumor Effect). | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31324057 | PubMed |
| 29,484,738 | Anti-cancer therapy with TNFα and IFNγ: A comprehensive review. | Cell Prolif | 2018 | https://conductscience.org/library/papers/29484738 | PubMed |
| 27,821,803 | Oncolytic adenovirus coexpressing interleukin-12 and shVEGF restores antitumor immune function and enhances antitumor efficacy. | Oncotarget | 2016 | https://conductscience.org/library/papers/27821803 | PubMed |
| 26,015,966 | Prevention of adverse events of interferon γ gene therapy by gene delivery of interferon γ-heparin-binding domain fusion protein in mice. | Mol Ther Methods Clin Dev | 2014 | https://conductscience.org/library/papers/26015966 | PubMed |
| 25,294,906 | MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitro. | Clin Cancer Res | 2014 | https://conductscience.org/library/papers/25294906 | PubMed |
| 23,570,383 | Interferon-γ-induced necrosis: an antitumor biotherapeutic perspective. | J Interferon Cytokine Res | 2013 | https://conductscience.org/library/papers/23570383 | PubMed |
| 22,160,384 | B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells. | Blood | 2012 | https://conductscience.org/library/papers/22160384 | PubMed |
| 18,279,103 | Targeted delivery of murine IFN-gamma using a recombinant fowlpox virus: NK cell recruitment to regional lymph nodes and priming of tumor-specific host immunity. | J Interferon Cytokine Res | 2008 | https://conductscience.org/library/papers/18279103 | PubMed |
| 11,454,803 | Interferon gamma inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis. | Gut | 2001 | https://conductscience.org/library/papers/11454803 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IFNA1 | 3,439 | PubTator's text mining | https://conductscience.org/library/genes/3439 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3933818
GET https://conductscience.org/api/papers/v1/3933818/references?page=2